When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AKRO - Akero Therapeutics to announce new data from AKR-001 Phase 2a NASH study
Akero Therapeutics Inc.
Akero Therapeutics (AKRO+2.4%) plans to announce additional efficacy and safety data, including biopsy results, from its Phase 2a BALANCED study of AKR-001 in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH), on June 30 (after hours trading).
More news on: Akero Therapeutics, Inc., Healthcare stocks news,